Contraindicated during pregnancy
No known risk of teratogenicity
Risk of fetal hypoxia based on mechanism of action
Avoid breastfeeding during treatment and 12 hours after discontinuing
Risk for infant vomiting, diarrhea, bradycardia, tachycardia, and seizures
Adult: Caution advised in impairment
Pediatric: N/A
Adult: Caution advised in impairment
Pediatric: N/A
Methylergonovine
Midodrine
Oxymetazoline
Terbutaline
Phenylephrine
Lubiprostone
Cabergoline
Oxytocin